Relationship between reproduction and population diversity
Reproduction (particularly recombination) introduces genetic differences. Allowing for evolution of new traits. Better adapted to enviornmental conditions (eg disease prevention) survive to reproduce, pushing survival traits to rest of population
Aneuploidy Def
Large scale germline genetic variation. 1(+) individual chromosomes either (a) have an extra copy or (b) are missing (ie In diploids there’s either (a) 3 chromosomal copies or (b) 1).
Down Syndrome Outline
aka trisomy 21. Example of Aneuploidy. 3 copies of chromosome 21 result in greater expression of it’s genes; lower cancer (solid tumour) risk but higher Alzheimer’s
Turner’s Syndrome Outline
Deletion of part of/full X chromosome in females. Aneuploidy. X genes are less expressed; infertility, short stature, deformities of heart
Translocation Def
Large scale germline genetic variation. Exchange of DNA in meiosis between 2 different chromosomes. Consequence severity depends on event (if in non-coding region no effect, if cut in coding region reduced gene expression)
Philadelphia Chromosome Outline
Translocation Example. When chromosome is cut off at band 9 gene expression of ALB1 (cell division repressor) is cut and combined with BCR1 (cell signaller, chromosome 22). Results in formation of constitutive oncogene causing chronic myeloid leukemia
Copy Number Variants Def
Large scale germline genetic variation. Deletions/duplications >1,000 base pairs on DNA (up to several million). Typically benign (and common) but if exceeding 1 million bps tend to be pathogenic
Huntington’s Disease Outline
Autosomal dominant CNV. Expanded CAG sequence in HTT gene results in toxic protein expansion. Leads to neuronal dysfunction affecting cognitive processing and movement. Earlier onset in later generation (CAG region keeps getting bigger)
What is the cause of CNVs
DNA polymerase slippage causing misalignment of DNA strand pairs. Resulting in; (a) misreading of a repeated sequence, where only 1 complementary sequence is produced where there should have been multiple (=shorter chain) or (b) production of extra sequence is produced as polymerase rereads a section (=longer chain, rarer event)
Microsatellite Def
Small germline genetic variation. 2-5bp repeats in DNA sequence (mainly non-coding). Quite common and most are benign
Single Nucleotide Polymorphism (SNP) Def
Small germline variation. Change of a single base pair (as compared to reference sequence). All individuals contain millions. Mainly benign but some have severe consequences
Sickle Cell Anemia Outline
Caused by a recessively inherited SNP in HBB gene resulting in a VAL aa replacing GLU in beta-globin subunit. Causes deformed cells resulting in severe pain and bloackage. Has heterozygote advantage in regions with high malaria risk (as mutation has higher malarial survival rates)
Insertions and Deletions (InDels Outline)
Small DNA sections (1-3 bps) that are deleted/duplicated. Everyone carries multiple in their genome. Vast majority are benign, risk of frameshift
Cystic Fibrosis Outline
Recessively inherited (heterogenous) CFTR protein mutations. Insertion of T and position 3905 causes frameshift resulting in damaged protein (Cl ion channel)
Pathogenic Mutations Outline
Changes in gene function that result in disease. Altered levels/timings of expression, alter splicing, different amino acid sequence and difefrent length of protein chain (non-sense mutation)
Features of large scale pathogenic variation
Largely different levels of gene expression. Gene protein levels are altered
Features of small scale pathogenic variation
Changes in amino acid sequence. Skipping/intro of exons, premature translation stops
Frameshift Outline
DNA polymerase in 1 bp off reading sequence correctly, wrong amino acid produced (different structure, chemical properties and overall function)
Genetic Variation in Malignant Cells Outline
Genomically unstable, allowing greater cancer evolution (survival advantage). Genetic mutations induce cancer and cancer cells create further mutations.
Function of cancer ‘driver’ mutations
continue genomic instability, bypassing of safety mechanisms (inhibition signals), rapid growth/division and metastasis
Passive Mutations Outline
Mutation in cells that don’t aid cancer growth
When can intrinsic mutation processes effect cancer risk
Gestation (division after fertilisation) to chemotherapy resistant reoccurrence
When can enviornmental exposures effect cancer risk
Childhood to chemotherapy ressistant reoccurance
When can mutator phenotype effect cancer risk
Benign tumour stages to chemotherpy ressistant reoccurance